LVNG RX review

What it is

LVNG RX is run by LVNG RX LLC, which lists a mailing address in Newark, Delaware. It describes itself as a telehealth platform that connects patients with independent, U.S.-licensed providers and state-licensed compounding pharmacies; it doesn't practice medicine, write prescriptions or dispense drugs. Its terms say the subscription price bundles the pharmacy's fee for the drug, the medical group's fee for the provider and LVNG RX's own platform fee, but the site doesn't name the medical group, the providers or the pharmacy. Beyond weight loss, it sells compounded sermorelin, tesamorelin, an Ipamorelin with CJC-1295 stack and NAD⁺. It's self-pay only. Support is by email and phone, weekdays from 9 a.m. to 5 p.m.

How it works

You start with a short online assessment tailored to the treatment you pick. An independent licensed provider reviews it and, if treatment is appropriate, writes a prescription that a partner compounding pharmacy prepares and ships in unmarked, temperature-controlled packaging, with free two-to-three-day shipping. For GLP-1s, the site lists a BMI of 27 or more, or 25 or more with a weight-related condition, as the usual fit, and existing conditions such as high blood pressure or type 2 diabetes don't automatically rule you out. If you're switching from another provider, you may continue at the same or an equivalent dose. After that, care runs through structured check-ins and direct messaging with your provider in the patient portal, with dose changes made at each step. The peptide programs follow the same route; for sermorelin, the provider may order baseline IGF-1 labs and typically runs treatment in courses with a reassessment around month three.

Pricing transparency

The homepage advertises compounded semaglutide "from $90/mo" beside a struck-through $249 and tirzepatide "from $149/mo" beside $299, covering the online provider visit, prescription, delivery and ongoing check-ins. The site doesn't say whether the lower figure is a first-month price, a longer-plan rate or a starting dose, and it notes that plans are confirmed after provider review. Its therapies page lists the lower-dose GLP-1 from $99 a month, the oral GLP-1 from $179, sermorelin from $199, tesamorelin from $249 and NAD⁺ from $179. The product pages promise flat pricing with no consultation charges or dose-change surcharges. Under its terms, you're charged when you order and every 30 days after until you cancel, with a reminder five to seven days before each charge. The program pages say memberships need 30 days' notice to cancel, while the terms let you turn off auto-refill up to 48 hours before the next charge. A prescription order can be canceled only within 24 hours, and refunds are limited to an unshipped order, a wrong or damaged product, or a provider who declines to prescribe; you pay nothing if you aren't approved.

Branded vs compounded

Providers can prescribe compounded semaglutide and compounded tirzepatide as weekly injections, a lower-dose GLP-1 protocol and an oral GLP-1, prepared by partner compounding pharmacies in the U.S. The site states that compounded medications are not FDA-approved, that their safety, effectiveness and quality haven't been verified by the FDA, and that they aren't the same as the brand-name drugs. The weight-loss figures it shows come from trials of the brand-name drugs, which it says. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered. Its peptide menu includes sermorelin, tesamorelin and Ipamorelin with CJC-1295, plus NAD⁺. LVNG RX doesn't display a LegitScript seal. A search of the FDA warning-letter database under its name and web address returned no letters.

Pros and watch-outs

The evidence behind what LVNG RX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• Sermorelin benefits: does it work? What the trials show

  A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.

• Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence

  A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How LVNG RX compares

A few alternatives worth a look, depending on what you’re optimizing for.

• MadeMed

  GLP-1 paired with NAD⁺ and sermorelin under one account

  See MadeMed →
• Shed

  A wide range of GLP-1 formats (injection, drops, lozenges, microdose)

  See Shed →
• KIN Health

  Cash buyers who want a low monthly compounded GLP-1 with named pharmacies and a monthly check-in, and may add NAD⁺ or sermorelin later

  See KIN Health →

More GLP-1 telehealth reviews: G-Plans · GetRelief Rx · Go Vida Plena · Eve · EverFit Medical · Evergreen Telehealth